GSMA
26.9.2016 18:31:16 CEST | Business Wire | Press release
The GSMA and the Metro Atlanta Chamber today announced more than 20 additional speakers for the ‘GSMA Mobility Live! – North America’ conference being held in Atlanta, 1-2 November 2016. Newly added to the conference programme are leading executives from Adobe, Amazon, BT, Cricket Wireless, the City of Atlanta, Home Depot, Samsung, Twitter and Verizon Wireless, among others. It brings the total number of confirmed speakers to more than 50 across the two-day conference, which will address topics such as 5G, cyber security, digital health, FinTech, the Internet of Things and smart cities.
New speakers announced today:
- Cathal McDaid, Chief Intelligence Officer, Adaptive Mobile
- Campbell Foster, Director, Product Marketing, Adobe
- Ashwin Karuhatty, Business Development, Smart Home, Amazon Web Services
- Kyle Rollins, CEO, Mammoth Solutions and Co-Founder, AMMO
- Laurie Baird, Innovation in Media, Broadcast Media
- Jason Cook, VP Security, BT Americas
- Cres Ferrell, VP, Buckhead Investment Partners
- Samir Saini, Commissioner and CIO, City of Atlanta
- Torri T. Martin, Director, SMARTATL, City of Atlanta
- Kevin Link, Chief Creative Officer, Convey
- Laura Poffenberger, Executive Director, Digital, Cricket Wireless
- Trey Loughran, CMO, Equifax
- David Smith, Mobile Product Manager, Home Depot
- Jason Robinson, VP, Product Management, Juvo
- Michael Becker, Co-Founder, mCordis
- Daryl Evans, SVP Mobile, Media and Advertising, MediaLink
- Christian Kotscher, CEO and Founder, MetroTech
- Gregory Lee, President and CEO, Samsung Electronics North America
- Theo Harvey, CEO, Synsormed
- Jeremy Legg, CTO, Turner
- Chad Tully, Head of Partnerships, Telco, Twitter
- Samir Vaidya, Director - Device Technology, Verizon Wireless
- Alan Dabbiere, Chairman, OneTrust and Chairman, Wandering WiFi
- Mike Finnerty, SVP and General Manager, Platform Products and Partnerships, The Weather Channel
- Kenny Ewan, CEO and Founder, WeFarm
The full list of speakers for GSMA Mobility Live! – North America, as well as the conference agenda, is available at http://www.mobile360series.com/north-america
“The latest speakers added to the GSMA Mobility Live! conference programme underline the broad range of industry topics that will be addressed in Atlanta, reflecting the transformative role that mobile is playing across multiple industries,” said Michael O’Hara, Chief Marketing Officer at the GSMA. “We are looking forward to thought leaders from the mobile industry and beyond joining us in Atlanta to explore the trends and issues shaping the dynamic North American mobile market.”
“This year’s speaker lineup showcases a robust slate of mobile leaders from the metro Atlanta region and across the globe,” said David Hartnett, Chief Economic Development Officer for the Metro Atlanta Chamber. “We are grateful for our partnership with the GSMA and their ability to help shine a global light and perspective on this event.”
Sponsors and partners for the event include AT&T (Platinum Sponsor); Huawei (Global Industry Supporter); and Bluetube, Home Depot, SAP, Syniverse and VMware AirWatch (Silver Sponsors).
Register Today for GSMA Mobility Live! – North America
Registration for GSMA Mobility Live! – North America is now open at http://www.mobile360series.com/north-america/#register .
Get Involved at GSMA Mobility Live! – North America
GSMA Mobility Live! – North America is part of the GSMA’s Mobile 360 Series of global conferences. For more information, including how to attend, exhibit or sponsor, please visit: www.mobile360series.com/north-america/ . Follow the latest developments and updates on Twitter, using the #GSMAMOBILITYLIVE hashtag or following @GSMA , on Facebook at www.facebook.com/Mobile360Series and LinkedIn on www.linkedin.com/company/gsma-mobile-360-series .
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with almost 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai and the Mobile 360 Series conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
About the Metro Atlanta Chamber
The Metro Atlanta Chamber (MAC) serves as a catalyst for a more prosperous and vibrant region. To advance economic growth and improve metro Atlanta's quality of place, MAC is focused on starting, growing and recruiting companies to the 29-county metro Atlanta region. The Chamber is also focused on growing the region's innovation economy by promoting and strengthening connections to drive Atlanta's innovation and entrepreneurial culture. MAC is committed to being an active voice for the business community, serving as an advocate for a competitive business climate and telling Atlanta's story.
For more information, visit www.metroatlantachamber.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160926006163/en/
Contact:
For the GSMA:
Eden Haile
+1 206 576 5560
Eden.Haile@webershandwick.com
or
Charlie
Meredith-Hardy
+44 7917 298428
CMeredith-Hardy@webershandwick.com
or
GSMA
Press Office
pressoffice@gsma.com
or
For
the Metro Atlanta Chamber:
Jennifer M. Spann
+1
404-586-8459
jspann@macoc.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom